Early-Age Onset Digestive Cancers – a Global Review of this Worrisome Trend
Early-age onset digestive cancers are worrisomely on the rise. To bring awareness to this topic, DiCE is partnering with its Member Organisation,...
Rising Liver Cancer Mortality in Europe Linked to Hepatitis B and C Infections Amidst Variance in Prevention and Treatment
Primary liver cancer is the sixth most common cause of cancer-related deaths in Europe. Infection with hepatitis B or C is one of the main risk fac...
DiCE’s Report from the AMMF Annual Cholangiocarcinoma Conference
The Alan Moremont Memorial Fund (AMMF) is the UK’s Cholangiocarcinoma charity. Its annual conference brings together UK and international experts...
Fruquintinib: A New Medicine for mCRC Recommended for Approval in Europe
DiCE supports the recommendation for approval of fruquintinib, a new medicine for metastatic colorectal cancer (mCRC). This medicine offers mCRC pa...
Extending Colonoscopy Screening Intervals: A New Approach to Colorectal Cancer Prevention
Having a colonoscopy is the best way to check and screen for colorectal cancer (CRC). A small camera on a bendy tube is passed through the anus and...
DiCE’s Report from the EASL Liver Cancer Summit
The EASL | The Home of Hepatology Liver Cancer Summit took place in Rotterdam, The Netherlands, from 22 – 24 February. This annual meeting i...
Biomarkers and their Role in the Diagnosis and Treatment of Cholangiocarcinoma (CCA)
Researchers in Italy have written a helpful and very detailed review of biomarkers specific to iCCA. Biomarkers are measurable medical signs that c...
